Procept BioRobotics Corp (NASDAQ: PRCT) is 17.85% higher on its value in year-to-date trading and has touched a low of $24.83 and a high of $51.90 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PRCT stock was last observed hovering at around $50.75 in the last trading session, with the day’s loss setting it -1.36%.
Currently trading at $49.39, the stock is 0.78% and 7.20% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.21 million and changing -2.68% at the moment leaves the stock 35.29% off its SMA200. PRCT registered 32.20% gain for a year compared to 6-month gain of 59.63%. The firm has a 50-day simple moving average (SMA 50) of $19.90 and a 200-day simple moving average (SMA200) of -$23.24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 1.98% loss in the last 1 month and extending the period to 3 months gives it a 42.46%, and is 1.77% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.29% over the week and 5.10% over the month.
Procept BioRobotics Corp (PRCT) has around 428 employees, a market worth around $2.49B and $136.19M in sales. Profit margin for the company is -77.75%. Distance from 52-week low is 98.91% and -4.83% from its 52-week high. The company has generated returns on investments over the last 12 months (-29.56%).
Procept BioRobotics Corp quarterly earnings per share for the current quarter are estimated at -$0.52 with sales reaching $40.76M over the same period.The EPS is expected to grow by 10.42% this year, but quarterly earnings will post 50.10% year-over-year. Quarterly sales are estimated to grow 67.00% in year-over-year returns.
219 institutions hold shares in Procept BioRobotics Corp (PRCT), with institutional investors hold 96.83% of the company’s shares. The shares outstanding are 50.47M, and float is at 48.24M with Short Float at 8.97%. Institutions hold 93.49% of the Float.
The top institutional shareholder in the company is FMR, LLC with over 6.68 million shares valued at $236.25 million. The investor’s holdings represent 14.76% of the PRCT Shares outstanding. As of Jun 29, 2023, the second largest holder is CPMG INC with 5.33 million shares valued at $188.38 million to account for 11.77% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 3.69 million shares representing 8.15% and valued at over $130.43 million, while T. Rowe Price Investment Management, Inc. holds 6.69% of the shares totaling 3.03 million with a market value of $107.03 million.
Procept BioRobotics Corp (PRCT) Insider Activity
A total of 2 insider transactions have happened at Procept BioRobotics Corp (PRCT) in the last six months, with sales accounting for 1 and purchases happening 1 times. The most recent transaction is an insider sale by Waters Kevin, the company’s EVP, CFO. SEC filings show that Waters Kevin sold 22,349 shares of the company’s common stock on Feb 12 at a price of $50.16 per share for a total of $1.12 million. Following the sale, the insider now owns 33523.0 shares.
Procept BioRobotics Corp disclosed in a document filed with the SEC on Feb 09 that Waters Kevin (EVP, CFO) sold a total of 28,677 shares of the company’s common stock. The trade occurred on Feb 09 and was made at $50.09 per share for $1.44 million. Following the transaction, the insider now directly holds 33523.0 shares of the PRCT stock.
Still, SEC filings show that on Feb 09, Nouri Alaleh (EVP, CLO, CORP. SEC.) disposed off 14,694 shares at an average price of $49.97 for $0.73 million. The insider now directly holds 47,351 shares of Procept BioRobotics Corp (PRCT).
Procept BioRobotics Corp (PRCT): Who are the competitors?
One of the company’s main competitors (and peers) include Merck & Co. Inc. (MRK) that is trading 20.20% up over the past 12 months.AbbVie Inc. (ABBV) lies in the list of competitors of the Procept BioRobotics Corp and is 14.64% higher over the same period from PRCTBoston Scientific Corp. (BSX) is 43.08% up on the 1-year trading charts.
